AGO2 and breast carcinoma: Conversely, SNP rs3864659 (A > C) in AGO2 protected against breast cancer risk (OR = 0.67; CI 0.46–0.96) in a Korean population, as observed by a case-control study involving 559 breast cancer cases vs. 567 controls [20].